NOVN HLDG : Quarterly Report - February 28, 2022

Disclosure Statement Pursuant to the Pink Basic Disclosure Guidelines

NOVATION HOLDINGS, INC

12 Park Mirage Lane

Rancho Mirage, CA 92270

1 [phone]

[e-mail]

8200

Quarterly Report

For the Period Ending: February 28, 2022

(the "Reporting Period")

As of February 28, 2022, the number of shares outstanding of our Common Stock was: 13,754,766,540

Indicate by check mark whether the company is a shell company (as defined in Rule 405 of the Securities Act of 1933 and Rule 12b-2 of the Exchange Act of 1934):

Yes: ☐

No: ☒

Indicate by check mark whether the company's shell status has changed since the previous reporting period:Yes: ☒

No: ☐

Indicate by check mark whether a Change in Control1 of the company has occurred over this reporting period:

Yes: ☐ No: ☒

1) Name and address(es) of the issuer and its predecessors (if any)

In answering this item, provide the current name of the issuer any names used by predecessor entities, along with the dates of the name changes.

NOVATION HOLDINGS, INC.

Formerly=Dragon Life Science Holdings, Inc. until 08-2021

Formerly=Novation Holdings, Inc. until 08-2017

1 "Change in Control" shall mean any events resulting in:

(i) Any "person" (as such term is used in Sections 13(d) and 14(d) of the Exchange Act) becoming the "beneficial owner" (as defined in Rule 13d-3 of the Exchange Act), directly or indirectly, of securities of the Company representing fifty percent (50%) or more of the total voting power represented by the Company's then outstanding voting securities;

• (ii) The consummation of the sale or disposition by the Company of all or substantially all of the Company's assets;

• (iii) A change in the composition of the Board occurring within a two (2)-year period, as a result of which fewer than a majority of the directors are directors immediately prior to such change; or

(iv) The consummation of a merger or consolidation of the Company with any other corporation, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity or its parent) at least fifty percent (50%) of the total voting power represented by the voting securities of the Company or such surviving entity or its parent outstanding immediately after such merger or consolidation.

Formerly=Allezoe Medical Holdings, Inc. until 11-2012

Formerly=Stanford Management, Ltd. until 2-2011

The state of incorporation or registration of the issuer and of each of its predecessors (if any) during the past five years; Please also include the issuer's current standing in its state of incorporation (e.g. active, default, inactive):

The Company was organized originally under the laws of the State of Delaware as Stanford Management Ltd., on September 24, 1998, and, effective on October 25, 2012, transferred our place of incorporation from Delaware to Florida and changed our corporate name to Novation Holdings, Inc.

Describe any trading suspension orders issued by the SEC concerning the issuer or its predecessors since inception:

None

List any stock split, stock dividend, recapitalization, merger, acquisition, spin-off, or reorganization either currently anticipated or that occurred within the past 12 months:

None

The address(es) of the issuer's principal executive office:

12 Park Mirage Lane

Rancho Mirage, CA 92270

The address(es) of the issuer's principal place of business:

Check box if principal executive office and principal place of business are the same address: ☒

Has the issuer or any of its predecessors been in bankruptcy, receivership, or any similar proceeding in the past five years?

Yes: ☐

No: ☒

If this issuer or any of its predecessors have been the subject of such proceedings, please provide additional details in the space below:

2)Security Information

Trading symbol:

Exact title and class of securities outstanding: CUSIP:

Par or stated value:

NOHO Common 66989U 10 9 .001

Total shares authorized: Total shares outstanding:

Number of shares in the Public Float2: Total number of shareholders of record:

35,000,000,000 as of date: February 28, 2022

13,754,766,540 as of date: February 28, 2022

10,287,442,916 as of date: February 28, 2022

72 as of date: February 28, 2022

All additional class(es) of publicly traded securities (if any):

Trading symbol:

Exact title and class of securities outstanding:	Preferred
CUSIP:
Par or stated value:	.001
Total shares authorized:	5,000,000
Total shares outstanding:	1,000,000
Transfer Agent

as of date: February 28, 2022 as of date: February 28, 2022

Name:	Pacific Stock Transfer Company
Phone:	[phone]
Email:	Paul Bednar <[e-mail]>
Address:	6725 Via Austi Pkwy, Suite 300
Las Vegas, NV 89119

Is the Transfer Agent registered under the Exchange Act?3 Yes: ☒

No: ☐

3)Issuance History

The goal of this section is to provide disclosure with respect to each event that resulted in any direct changes to the total shares outstanding of any class of the issuer's securities in the past two completed fiscal years and any subsequent interim period.

Disclosure under this item shall include, in chronological order, all offerings and issuances of securities, including debt convertible into equity securities, whether private or public, and all shares, or any other securities or options to acquire such securities, issued for services. Using the tabular format below, please describe these events.

A. Changes to the Number of Outstanding Shares

Check this box to indicate there were no changes to the number of outstanding shares within the past two completed fiscal years and any subsequent periods: ☐

2 "Public Float" shall mean the total number of unrestricted shares not held directly or indirectly by an officer, director, any person who is the beneficial owner of more than 10 percent of the total shares outstanding (a "control person"), or any affiliates thereof, or any immediate family members of officers, directors and control persons.

3 To be included in the Pink Current Information tier, the transfer agent must be registered under the Exchange Act.

Shares Outstanding as of Second Most Recent Fiscal Year End: Opening Balance Date 08.31.17 Common: 8,474,145,740 Preferred: 1,000,000	*Right-click the rows below and select "Insert" to add rows as needed.
Date of Transaction	Transaction type (e.g. new issuance, cancellation , shares returned to treasury)	Number of Shares Issued (or cancelled)	Class of Securities	Value of shares issued ($/per share) at Issuance	Were the shares issued at a discount to market price at the time of issuance? (Yes/No)	Individual/ Entity Shares were issued to (entities must have individual with voting / investment control disclosed).	Reason for share issuance (e.g. for cash or debt conversion) -OR-Nature of Services Provided	Restricted or Unrestricted as of this filing.	Exemption or Registration Type.
11.09.17	New	100,000,000	Common	.001	No	TBCF Partners LLC Caragol, William	Debt Conversion	Restricted	144
03.02.21	New	500,000,000	Common	.001	No	Sojourn Investments Casey Jensen	Debt Conversion	Restricted	144
04.14.21	New	900,000,000	Common	.001	No	Sojourn Investments Casey Jensen	Debt Conversion	Restricted	144
08.16.23	New	900,000,000	Common	.001	No	Sojourn Investments Casey Jensen	Debt Conversion	Restricted	144
09.03.21	New	500,000,000	Common	.001	No	Luis Rodriguez Agent for Yaoliu Health Technology Shenzhen Co. LTD	Settlement and Release Agreement / Cancelation of Series A Preferred	Restricted	144
09.10.21	New	980,620,800	Common	.0005	yes	Solar Advisors Limited Andrew Byers	Debt Conversion	Restricted	144
10.11.2021	New	900,000,000	Common	.001	No	Sojourn Investments Casey Jensen	Debt Conversion	Restricted	144
01.25.2022	New	500,000,000	Common	.001	No	Alejandro Perez	Acquisition CraftClouds, LLC	Restricted	144

Shares Outstanding on Date of This Report:EndingBalanceEndingBalance: Date 02/28/2022 Common: 13,754,766,540 Preferred: 1,000,000

Example: A company with a fiscal year end of December 31st, in addressing this item for its quarter ended September 30, 2020, would include any events that resulted in changes to any class of its outstanding shares from the period beginning on January 1, 2018 through September 30, 2020 pursuant to the tabular format above.

Use the space below to provide any additional details, including footnotes to the table above:

B. Debt Securities, Including Promissory and Convertible Notes

Use the chart and additional space below to list and describe all outstanding promissory notes, convertible notes, convertible debentures, or any other debt instruments that may be converted into a class of the issuer's equity securities.

Check this box if there are no outstanding promissory, convertible notes or debt arrangements: ☐

Date of Note Issuance	Outstanding Balance ($)	Principal Amount at Issuance ($)	Interest Accrued ($)	Maturity Date	Conversion Terms (e.g. pricing mechanism for determining conversion of instrument to shares)	Name of Noteholder (entities must have individual with voting / investment control disclosed).	Reason for Issuance (e.g. Loan, Services, etc.)
08.01.14	135,087.15	135,087.15	78,402	08.01.15	50% of the lowest closing bid price for the previous twenty (20) consecutive trading days.	Michael Gelmon	Loan
03.01.16	14,000	147,500	77,466	03.01.17	Lowest of a) 50% of 20 day lowest trading price or b) in the event the stock price trades at or below $.0001, conversion price is fixed at $.00005 per share of Common Stock.	Sojourn Investments Casey Jensen	Loan
03.01.17	147,500	147,500	62,716	03.01.18	Lowest of a) 50% of 20 day lowest trading price or b) in the event the stock price trades at or below $.0001, conversion price is fixed at $.00005 per share of Common Stock.	Sojourn Investments Casey Jensen	Loan

Use the space below to provide any additional details, including footnotes to the table above:

4)Financial Statements

A. The following financial statements were prepared in accordance with:

☒ U.S. GAAP

☐ IFRS